Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Robert Chisholm joins Anavex's board, as CFO David Tousley departs

This article was originally published in Scrip

Executive Summary

Robert Chisholm, a finance and administration executive with more than 25 years' experience, has joined Anavex's board of directors to advise on corporate finance and strategic business initiatives. Mr Chisholm is currently an officer and partner of Emprise Capital Corp, a company which gives advice on managing corporate finances. Anavex has also appointed its president, Harvey Lalach, as interim chief financial officer, as current CFO David Tousley stands down.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC012975

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel